The total return over the past 12 months is -91.64% vs. +16.94% for the S&P 500. So far it's up -85.52% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (91.64%) | (54.87%) | (67.74%) | (57.70%) | N/A | N/A |
| Total Return CAGR | (91.64%) | (54.87%) | (67.74%) | (57.70%) | N/A | N/A |
| Revenue CAGR | (12.24%) | (2.36%) | (13.28%) | +0.01% | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Arcadia Biosciences, Inc. (RKDA)
| Year | Start price | End price | RKDA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.98 | $0.29 | (85.52%) | +14.51% | (100.03%) |
| 2025 | $5.92 | $1.98 | (66.55%) | +17.72% | (84.27%) |
| 2024 | $3.13 | $5.92 | +89.14% | +24.89% | +64.25% |
| 2023 | $10.84 | $3.13 | (71.13%) | +26.19% | (97.32%) |
| 2022 | $41.60 | $10.84 | (73.94%) | (18.17%) | (55.77%) |
| 2021 | $101.20 | $41.60 | (58.89%) | +28.74% | (87.63%) |
| 2020 | $219.20 | $101.20 | (53.83%) | +18.37% | (72.20%) |
| 2019 | $126.80 | $219.20 | +72.87% | +31.22% | +41.65% |
| 2018 | $220.00 | $126.80 | (42.36%) | (4.56%) | (37.80%) |
| 2017 | $736.00 | $220.00 | (70.11%) | +21.70% | (91.81%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
